About

MaxQ AI is at the forefront of Medical Diagnostic AI. We develop software that uses artificial intelligence to interpret medical images, such as CT scans, and surrounding patient data. Our software enables doctors to make faster, more accurate decisions when diagnosing stroke, brain trauma, and other serious conditions.

MISSION

Our mission is to meaningfully reduce misdiagnosis and healthcare costs
by making artificial intelligence intrinsic to the diagnostic process for
time sensitive and life-threatening conditions. When we’re successful,
we’ll have elevated the global standard of acute medical care
by providing universal access to expert diagnosis.

Key Facts *

EVERY PATIENT DESERVES EQUAL ACCESS TO EXPERT CARE

THE OPPORTUNITY - MISDIAGNOSIS

A study at Johns Hopkins estimated that medical errors are the #3 cause of death in the U.S. The overall misdiagnosis in healthcare is estimated at 30%, and can be as high as 50% in certain situations. This means that roughly 1 in 3 and often 1 in 2 patients may be misdiagnosed. MaxQ AI believes this can be meaningfully improved. The company aspires to drive accuracy rates north of 95% regardless of geography or the time of day.

STROKE AND TRAUMATIC BRAIN INJURY

Stroke and traumatic brain injury are two areas where MaxQ AI has initially focused. The statistics are staggering. Stroke is the second leading cause of death globally. In the U.S. alone, someone experiences a stroke or traumatic brain injury every 9 seconds (nearly 3.6 million people per year). Stroke is the #1 cause of disability.

The American Heart/Stroke Association forecasts that by 2030, there will be nearly 3.4 million stroke cases annually and the annual cost will reach $240 billion. The cost of a missed brain bleed can be $150,000 per year patient. But, the economic cost of treating a misdiagnosed patient is nothing compared to the devastation to the families.

MARKET APPROACH

Our approach to the market has been to partner with industry-leading and trusted CT OEMs and PACS software companies. MaxQ AI’s diagnostic suite is being deployed today directly onto CT and PACS systems.

OUR FOCUS - TIME SENSITIVE & LIFE THREATENING CONDITIONS

We are focused on building applications to address time sensitive, life-threatening conditions, such as stroke and traumatic brain injury. And this is only the beginning. A new era is here, MaxQ AI is ushering in empowered care, the partnership between AI and the skilled caregiver to bring expert care to every patient.

OUR PRODUCTS

The complete Accipio platform will support radiology, the emergency department and neuroradiology teams with a fully-automated solution. Accipio will use MaxQ Al’s INSIGHTTM method, providing prioritization (lx1), annotation (Ax2), and expert-level diagnostic rule out (Dx2). The complete ICH solution for head trauma and stroke promises to:

  • Greatly increase ICH detection and reduce missed hemorrhage through real-time triaged and prioritized notification of non-contrast head CT – because minutes matter
  • Enhance escalation and intervention confidence, including mobilization of Stroke, tPA and Operating Room teams for mechanical clot removal; the right care readied faster
  • Assist stroke treatment: including tPA administration and mechanical intervention, that can help avoid errors leading to clinical, economic, and potentially litigious issues

OUR TECHNOLOGY

Our products are based on artificial intelligence, deep learning, machine vision, and world class clinical partners. We have developed a platform capable of concurrently considering medical imaging along with other patient data. Our Medical Diagnostic AI is designed to enable doctors to make faster, more accurate decisions when diagnosing time-sensitive life-threatening conditions.

TEAM

The MaxQ AI team of artificial intelligence, machine learning, deep learning, and algorithmic experts, together with our dedicated Board of Directors and Scientific and Medical Advisory Board, are changing the standards of emergency room treatment and cost of care.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
GENE SARAGNESE
CEO

Prior to joining MaxQ AI, Gene was CEO of Philips Imaging Systems, a $7 billion business, for 6 years. He previously was an executive at GE Healthcare for 13 years. Gene was VP & GM of CT and Molecular imaging (a $2.7 billion business), served as GE Healthcare CTO and General Manager of Global Sourcing. Gene started his career in aerospace with roles at Lockheed Martin, Martin Marietta, GE Astro Space and RCA Astro Space.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
MICHAEL ROSENBERG
CO-FOUNDER & CHIEF FINANCIAL OFFICER

22+ years of finance, operations and business development experience in enterprise software focused in Big Data Analytics, Telecom, BCP/DR/COGS and B2B eCommerce. Extensive experience in global markets.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
ROBERT MEHLER
CO-FOUNDER & CHIEF OPERATING OFFICER

20+ years of extensive operational and strategy consulting experience in the enterprise software space. Most recently, head of Global Business Operations for GENBAND fring.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
CHRIS SCHNEE
S.VP COMMERCIAL OPERATIONS

22+ years global commercial leadership, sales, marketing, and business operations experience within healthcare, medical device, medical imaging, and industrial market sectors. Prior to joining MaxQ AI served as VP Global Marketing and International Sales, Centurion Medical and General Manager, Christie Medical Holdings.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
OFER PINHASI
VP PRODUCT MANAGEMENT

25+ years of technology and innovation leadership in software and medical imaging. Prior to MaxQ AI, Ofer managed CT and functional imaging product development programs in GE Healthcare and Philips.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
DR. JOSHUA SCHULMAN
VP CLINICAL, REGULATORY AND QUALITY AFFAIRS

18+ years of clinical R&D and worldwide regulatory experience in imaging, medical devices and pharmaceuticals for academia, government and industry. PhD in Neurobiology.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
MAYA MICHELSOHN
VP FINANCE & PRINCIPAL ACCOUNTING OFFICER

18 years of finance experience for large corporate and banking institutions on a global basis. Extensive experience in public company financial reporting and controls. Most recently, Director, Corporate Finance at Teva Pharmaceuticals. Certified Public Accountant.

Pay for Performance, Quality Outcomes, Stroke Center, MaxQ AI
YANIV BEN-ZRIHAM
VICE PRESIDENT R&D

20 years of technology, innovation and leadership in high-tech and medical device leading companies. Prior to MaxQ AI, Yaniv has managed cross functional multidisciplinary R&D teams composed of integration, HW, SW, FW, Algorithm & System Engineers at Intel, Philips Healthcare, Given-Imaging & Biosense-Webster.

Scientific and Medical Advisory Board

DR. MICHAEL LEV

Mass General Hospital Boston
Director, Emergency Radiology and Emergency Neuroradiology.
Professor, Harvard Medical School

DR. GABRIEL POLLIACK

Chairman of the National Imaging Council Committee - for Sharing of Diagnostic Images

DR. PAUL SINGH

Assistant Professor of NeuroEndovascular Surgery & Vascular Neurology, Rutgers Neurological Institute of Rutgers New Jersey Medical School.

DR. YAAKOV APPLBAUM

Capital Health – New Jersey
Chairman and Medical Director, Department of Radiology

DR. AJAY CHOUDHRI

Capital Health – New Jersey
Director, Vascular and Interventional
Radiology Assistant Director,
Radiology, Capital Health

DR. DAVID HAYNOR

M.D., Ph.D., Neuro-radiologist and Assistant Professor of Radiology and Neurological Surgery at University of Washington Hospitals

DR. JALAL ANDRE

M.D., D.A.B.R., Director of Neurological MRI and MRI safety officer at Harborview Medical Center and a University of Washington, Assistant Professor of Radiology

Board of Directors

IAN WEINGARTEN
Chairman
GENE SARAGNESE
CEO
SIM MANN
Chief Strategy Officer, Exigent Capital
BARAK SALOMON
NTT DOCOMO Ventures advisor, Former Principal at Viola Growth
EITAN MACHOVER
Former GE Executive, General Partner Ziegler Meditech Equity Partners
Scott Snyder
Partner, Digital and Innovation at Heidrick & Struggles, Senior Fellow The Wharton School
Samantha Allison
Principal, Leverage Advisors. Former General Manager at GE Healthcare Financial Services

Join

If you’re passionate about changing patient care forever through ground-breaking science and technology’s contribution to local and global healthcare… If you’re excited about the idea of less time in hospital and more time doing the things you love, moving from being a reader of images to a core part of the diagnostic care-continuum. If you agree that millions of private and government dollars can be better spent with more accurate emergency room, operating room, and patient treatment, resulting in better immediate care and significantly lower long-term care… We’re interested in you…

Send us your CV and tell us how you’d like to become part of our team, or apply to one of our open positions below:

Current Opportunites

ALGORITHMS SENIOR MACHINE LEARNING RESEARCHER

TEL AVIV

Apply

FULL STACK WEB/APPLICATION/CLOUD DEVELOPER

TEL AVIV

Apply

Director Commercial Operations

UK

Apply

Director Commercial Operations

GERMANY

Apply

Director Commercial Operations

JAPAN

Apply

Product Manager

USA

Apply

Product Manager

TEL AVIV

Apply

Deep Learning Research Engineer

TEL AVIV

Apply

Machine Learning Developer

TEL AVIV

Apply

DevOps

TEL AVIV

Apply

Software Engineer

TEL AVIV

Apply